Search company, investor...

Executives

2

Board of Directors

5

Sandstone Diagnostics Management Team

2 Team Members

Sandstone Diagnostics has 2 executives. Sandstone Diagnostics's current Chief Executive Officer is Gary G. Altman.

Name

Work History

Title

Status

Gary G. Altman

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Gary G. Altman

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Status

Current

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Sandstone Diagnostics Board of Directors

5 Board of directors

Sandstone Diagnostics has 5 board of directors, including Faith Charles.

Name

Firm

Work History

Other Seats

Faith Charles

Faith has authored articles and presents on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs. She has been featured in Crain’s New York and profiled in The New York Times. She has earned recognition as a BTI Client Service All-Stars for service excellence, and from LMG Life Sciences for transactional and Life Sciences expertise. Faith is also on the board of several early stage companies. Faith has spoken for and served as a panelist and moderator for such organizations as Advamed, Springboard, and North Carolina Biotechnology Center. She has authored articles on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs.

Sandstone Diagnostics

Gary Altman

Dr. Altman is an investor, entrepreneur and leader of large and small scientific organizations. His experiences include senior management positions at Beckman Coulter, Sequoia Pharmaceuticals, and Sandstone Diagnostics as well as advisor to GE Healthcare, Terumo-CaridianBCT and GenVec among others. He earned a PhD in biochemistry/virology and held an NSF Post-Doctoral Fellowship in the BioPhysics and McArdle Laboratories at the University of Wisconsin, Madison.

Sandstone Diagnostics

Karen Drexler

Karen Drexler has served as a ResMed director since November 2017, and is a member of our compensation and nominating and governance committees. Ms. Drexler is a serial entrepreneur with expertise in the fields of digital health, medical devices, and diagnostics. Currently, she serves on the boards of Outset Medical (NASDAQ: OM), a medtech company innovating dialysis treatment, where she is a member of both the compensation and nomination and governance committees; Tivic Health, (NASDAQ: TIVC), a bioelectric medicine company focused on relief of congestion and sinus pain, where she chairs the compensation and nomination and corporate governance committees and serves on the audit committee; and EBR Systems, Inc. (ASX: EBR), maker of a wireless cardiac pacing system for people with heart failure, where she chairs the remuneration and governance committee. Ms. Drexler is also on the board of two private companies: VIDA Diagnostics, the leading company in AI-powered lung intelligence solutions; and Huma.ai, a company using natural language queries to extract unique insights from complex medical data. From 2016 to 2020, Ms. Drexler was the CEO and a board member of Sandstone Diagnostics, Inc., a private company developing instruments and consumables for point-of-care medical testing. From 2011 to 2017, she served as board chair of Hygieia, Inc., a digital insulin therapy company, and remains an advisor to the CEO. She also acts as a senior strategic advisor for other early-stage companies, and spent 11 years on the board of the Keller Center for Innovation in Engineering Education at Princeton University. Ms. Drexler is an active mentor and advisor with Astia, a global nonprofit that supports high-potential female founders. She is a founding member of Astia Angels, a network of individual investors who fund such founders, and a lead mentor with StartX, the Stanford University incubator. She is also on the Life Science and Women’s Health Councils for Springboard, an accelerator for women-led technology-oriented companies. Through her work with Astia, Springboard, and StartX, she interacts with many promising young medtech companies. Ms. Drexler was founder, president, and CEO of Amira Medical Inc., a private company focused on minimally invasive glucose monitoring technology, from 1996 until it was sold to Roche Holding AG in 2001. Before Amira Medical, she held management roles at LifeScan and played a key role in its sale to Johnson & Johnson (NYSE: JNJ). Ms. Drexler graduated magna cum laude with a B.S.E. in chemical engineering from Princeton University, and earned an M.B.A. with honors from the Stanford University Graduate School of Business.

Sandstone Diagnostics

Priya Balachandran

Sandstone Diagnostics

Sharon Vosmek

Sharon has held a number of senior finance roles within several sectors including marketing, manufacturing and IT

Sandstone Diagnostics

Name

Faith Charles

Gary Altman

Karen Drexler

Priya Balachandran

Sharon Vosmek

Firm

Work History

Faith has authored articles and presents on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs. She has been featured in Crain’s New York and profiled in The New York Times. She has earned recognition as a BTI Client Service All-Stars for service excellence, and from LMG Life Sciences for transactional and Life Sciences expertise. Faith is also on the board of several early stage companies. Faith has spoken for and served as a panelist and moderator for such organizations as Advamed, Springboard, and North Carolina Biotechnology Center. She has authored articles on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs.

Dr. Altman is an investor, entrepreneur and leader of large and small scientific organizations. His experiences include senior management positions at Beckman Coulter, Sequoia Pharmaceuticals, and Sandstone Diagnostics as well as advisor to GE Healthcare, Terumo-CaridianBCT and GenVec among others. He earned a PhD in biochemistry/virology and held an NSF Post-Doctoral Fellowship in the BioPhysics and McArdle Laboratories at the University of Wisconsin, Madison.

Karen Drexler has served as a ResMed director since November 2017, and is a member of our compensation and nominating and governance committees. Ms. Drexler is a serial entrepreneur with expertise in the fields of digital health, medical devices, and diagnostics. Currently, she serves on the boards of Outset Medical (NASDAQ: OM), a medtech company innovating dialysis treatment, where she is a member of both the compensation and nomination and governance committees; Tivic Health, (NASDAQ: TIVC), a bioelectric medicine company focused on relief of congestion and sinus pain, where she chairs the compensation and nomination and corporate governance committees and serves on the audit committee; and EBR Systems, Inc. (ASX: EBR), maker of a wireless cardiac pacing system for people with heart failure, where she chairs the remuneration and governance committee. Ms. Drexler is also on the board of two private companies: VIDA Diagnostics, the leading company in AI-powered lung intelligence solutions; and Huma.ai, a company using natural language queries to extract unique insights from complex medical data. From 2016 to 2020, Ms. Drexler was the CEO and a board member of Sandstone Diagnostics, Inc., a private company developing instruments and consumables for point-of-care medical testing. From 2011 to 2017, she served as board chair of Hygieia, Inc., a digital insulin therapy company, and remains an advisor to the CEO. She also acts as a senior strategic advisor for other early-stage companies, and spent 11 years on the board of the Keller Center for Innovation in Engineering Education at Princeton University. Ms. Drexler is an active mentor and advisor with Astia, a global nonprofit that supports high-potential female founders. She is a founding member of Astia Angels, a network of individual investors who fund such founders, and a lead mentor with StartX, the Stanford University incubator. She is also on the Life Science and Women’s Health Councils for Springboard, an accelerator for women-led technology-oriented companies. Through her work with Astia, Springboard, and StartX, she interacts with many promising young medtech companies. Ms. Drexler was founder, president, and CEO of Amira Medical Inc., a private company focused on minimally invasive glucose monitoring technology, from 1996 until it was sold to Roche Holding AG in 2001. Before Amira Medical, she held management roles at LifeScan and played a key role in its sale to Johnson & Johnson (NYSE: JNJ). Ms. Drexler graduated magna cum laude with a B.S.E. in chemical engineering from Princeton University, and earned an M.B.A. with honors from the Stanford University Graduate School of Business.

Sharon has held a number of senior finance roles within several sectors including marketing, manufacturing and IT

Other Seats

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.